Biosurfactant MEL-A enhances cellular association and gene transfection by cationic liposome
Saki Igarashi1, Yoshiyuki Hattori, Yoshie Maitani
1Institute of Medicinal Chemistry, Hoshi University, Ebara 2-4-41, Tokyo 142-8501, Japan.
Abstract:
Mannnosylerythritol lipid A (MEL-A), a biosurfactant produced by microorganisms, has many biological activities. To enhance the gene transfection efficiency of a cationic liposome, we prepared a MEL-liposome (MEL-L) composed of 3beta-[N-(N',N'-dimethylaminoethane)-carbamoyl] cholesterol (DC-Chol), dioleoyl phosphatidylethanolamine (DOPE) and MEL-A, and investigated its transfection efficiency in human cervix carcinoma Hela cells. MEL-L was about 40 nm in size, and the MEL-L/plasmid DNA complex (MEL-lipoplex) remained an injectable size (169 nm). MEL-A induced a significantly higher level of gene expression, compared to commercially available Tfx20 and the liposome without MEL-A (Cont-L). Analysis of flow cytometric profiles clearly indicated that the amount of DNA associated with the cells was rapidly increased and sustained by addition of MEL-A to the liposome. Confocal microscopic observation indicated that the MEL-lipoplex distributed widely in the cytoplasm, and the DNA was detected strongly in the cytoplasm and around the nucleus, compared with Cont-L. These results suggested that MEL-A increased gene expression by enhancing the association of the lipoplexes with the cells in serum. MEL-L might prove a remarkable non-viral vector for gene transfection and gene therapy.
Insights
Mannnosylerythritol lipid A (MEL-A) enhances gene transfection. MEL-A liposomes (MEL-L) improved DNA delivery and expression in Hela cells, showing potential as a non-viral vector for gene therapy.
Area of Science:
- Biotechnology
- Molecular Biology
- Biochemistry
Background:
- Mannnosylerythritol lipid A (MEL-A) is a microbial biosurfactant with diverse biological activities.
- Gene transfection efficiency is crucial for gene therapy and requires effective delivery vectors.
- Cationic liposomes are commonly used for gene delivery but can be improved for enhanced efficiency.
Purpose of the Study:
- To enhance gene transfection efficiency using a novel MEL-A-based liposome (MEL-L).
- To investigate the size, stability, and transfection capabilities of MEL-L/plasmid DNA complexes (MEL-lipoplexes).
- To compare the gene expression levels mediated by MEL-L with commercial transfection agents and a control liposome.
Main Methods:
- Preparation of MEL-liposomes (MEL-L) using DC-Chol, DOPE, and MEL-A.
- Characterization of MEL-L size and MEL-lipoplex size using dynamic light scattering.
- Assessment of gene transfection efficiency in Hela cells via gene expression analysis (flow cytometry, confocal microscopy).
Main Results:
- MEL-L/plasmid DNA complexes (MEL-lipoplexes) were stable and injectable (169 nm).
- MEL-A significantly increased gene expression compared to Tfx20 and control liposomes (Cont-L).
- MEL-A enhanced cellular DNA association and distribution within the cytoplasm and around the nucleus.
Conclusions:
- MEL-A incorporation into liposomes improves gene transfection efficiency.
- MEL-A enhances the cellular uptake and intracellular localization of plasmid DNA.
- MEL-L represents a promising non-viral vector for gene transfection and gene therapy applications.
Related Concept Videos
Micelles
Bioavailability Enhancement: Drug Permeability Enhancement
Bioavailability Enhancement: Drug Solubility Enhancement


